• Ixekizumab superior to adalimumab for joint, skin improvement in PsA

    2 monthes ago - By Healio

    Ixekizumab is superior to adalimumab in simultaneously improving both joint and skin disease in patients with psoriatic arthritis who have had an inadequate response to conventional synthetic DMARDs, according to data published in the Annals of the Rheumatic Diseases.
    “This is the first head-to-head study of two biologic agents in PsA,” Philip J. Mease, MD, of the Swedish Medical Center, in Seattle, told Healio Rheumatology. “Head-to-head studies allow us to truly compare two agents because the medications are studied in the same population cohort as opposed to indirect
    Read more ...

     

  • New ankle prosthesis improves patient experience with arthritis

    2 monthes ago - By Healio

    CHICAGO - Use of a new total ankle prosthesis improved the experience of patients with end-stage arthritis, according to results from a study presented at the American Orthopedic Foot & Ankle Society Annual Meeting.
    Tim Daniels, M D, FRCSC, orthopedic surgeon, chief of the division of orthopedic surgery of St. Michael's Hospital and professor at the University of Toronto, and colleagues conducted a retrospective study that examined patient outcomes after total ankle replacement using the Cadence Total Ankle System .
    The study included 31 patients who
    Read more ...